Agenda Details | ASGCT Annual Meeting

Detailed Program

Friday, May 19 2023
10:15 AM – 12:00 PM PT

From the Needle to the Nucleus: Exploring Key Points of Vector Design & Development

This session will explore several key aspects of the development of gene therapy products, including developing the viral vector, the connection between vector design and manufacturing, tracking in vivo dynamics, and product durability. These topics will provide further insight into the nonclinical development and clinical translation of future viral-based gene therapy programs.

Session Details

10:15 AM – 12:00 PM - Concourse Hall 150 & 151

Co-Chair

Joseph Lee. , MA

10:15 AM – 12:00 PM - Concourse Hall 150 & 151

Co-Chair

Adam Cockrell, PhD. Solid Biosciences, MA

10:16 AM – 10:40 AM - Concourse Hall 150 & 151

AAV in vivo Tracking and Microscopy

Katherine Ferrara, PhD. Stanford University, Palo Alto, CA

10:40 AM – 11:05 AM - Concourse Hall 150 & 151

Disease gene-agnostic gene therapy to prolong vision

Connie Cepko, PhD. Harvard Medical School and HHMI, Boston, MA

11:05 AM – 11:30 AM - Concourse Hall 150 & 151

In vivo Cell-specific Gene Delivery Achieved Through a Re-targetable Fusogen Platform

Jagesh V. Shah, PhD. Sana Biotechnology, Seattle, WA

11:30 AM – 11:55 AM - Concourse Hall 150 & 151

Spatial transcriptomics for pooled AAV profiling

Min Jee Jang, PhD. Caltech, Pasadena, CA